About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, June 13th, 2014

The QualityStocks
Daily Stock List


TransAct Energy Corp. (TEGY)

Real Pennies, SmarTrend Newsletters, and Zacks reported on TransAct Energy Corp. (TEGY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in San Antonio, Texas, TransAct Energy Corp. engages in the production of sustainable energy worldwide, with a focus on energy from waste, geothermal, solar and wind. TransAct has a team of experts, experienced globally in developing energy from waste processing plants, big hydro and geothermal power plants. In 2010, the Company launched its “Energy from Waste” division. TransAct Energy’s shares trade on the OTC Markets’ OTCQB.

Currently, TransAct Energy’s focus is waste technologies and resources. The Company’s current products are usable energy (electricity, fuel and liquefied petroleum gas (LPG)), and usable carbon and recyclables (metal, nylon, gravel). TransAct’s business is the building/owning/operating (BOO) of the only, profitable, emissions free, carbon negative, industrial scale, waste processing plant, which produces fuel, LPG, Carbon Black and recycled materials from municipal solid waste (MSW), medical waste, agricultural waste, as well as industrial waste.

Recently, Transact Energy announced that it formally entered a Services Agreement with Fichtner Consulting Engineers Ltd. based in Manchester, UK. The formal signing of the Agreement occurred on May 12, 2014, providing for the feasibility analysis and design of the proposed TransAct Energy Zero Emissions Waste Optimization Plant ™ (Z.E.W.O.P. ™) for Puebla, Mexico. Fichtner is one of the world's foremost independent engineering consultancy firms.

Yesterday, Transact Energy announced that by way of its partners, Puebla Waste Consortium secured, under contract, the first of two plant sites in Puebla, Mexico. The first site is at the Chahcapa Industrial Park in the township of Chachapa on the outskirts of Puebla, Mexico. It is a Greenfield site of 3.4 Hectares (8.3 acres). It is minutes from the highway and bypass system enabling easy access in and out of Puebla's MSW collection areas.

Other sites are under consideration for the second plant in Puebla. A vital strategy of the TransAct Zero Emissions Waste Optimization Plants ™ (Z.E.W.O.P. TM) is to also decrease the carbon footprint of waste collection by locating Z.E.W.O.P ™ around the city for easy access. 

TransAct Energy Corp. (TEGY), closed Friday's trading session at $0.07, up 18.64%, on 33,200 volume with 3 trades. The average volume for the last 60 days is 16,863 and the stock's 52-week low/high is $0.024/$0.09.

Medifirst Solutions, Inc. (MFST)

PennyStocks24 reported on Medifirst Solutions, Inc. (MFST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medifirst Solutions, Inc. looks for innovative medical and healthcare products and technologies targeted to medical and healthcare professionals and everyday consumers. It plans to develop and establish a consumer and professional medical base and clientele to be used as a pipeline that will allow for expansion with new products and services. Medifirst’s commitment is to provide innovative drug free and pain free treatments, services, and products for people to make better and healthier choices and improve their quality of life. 

Medifirst is offering its LED Botanical Light Therapy in its Boca Raton, Florida office. Medifirst launched a new Health and Wellness Division, called Medi-First Light Therapy Systems with its new and pioneering LED Botanical Light Therapy Systems. The Boca Raton location focuses on the Light Therapy Systems for cosmetic and anti-aging therapy. The Company is creating an infrastructure based on the Botanical Light Therapy Systems and the very positive results it indicates it is achieving. The LED Botanical Light Therapy Systems has not been evaluated by the Food and Drug Administration (FDA).

Medifirst has filed for two publication trademarks with the United States Patent and Trademark Office (USPTO). The name of the first publication is “Marijuana News & Report". In addition, Medifirst is creating regional publications including "Colorado Buds" and “Florida Cannabis”.

The Company has completed an agreement with Atmospheric Water Solution, a company that generates water through using an advanced patented technology. The water generating machines extract water directly from the air. Medifirst Solutions announced this past February that it acquired Consumer Resources Consultants, Inc., a company that provides online remote technical support to PC users. The acquisition is part of Medifirst’s plan to increase its internal technology infrastructure and add technical and digital services and expertise to its internal business operations.

In April, Medifirst announced it completed an agreement with "The Original Ganja Gourmet" to offer its award winning brand and edible recipes and products from Colorado to the Florida market as marijuana is legalized. The Ganja Gourmet is one of the most well-known medical marijuana dispensaries. It offering a full line of cannabis and one of the most extensive selections of edibles.

Medifirst Solutions also announced it will be launching a new division called Medi-Safe Products under its Medical Marijuana banner. Moreover, Medifirst recently announced it completed a business development agreement with Native Holdings, LLC. Native Holdings has a long standing business relationship with the Seminole Tribe of Florida, owners of the Hard Rock Hotel & Casino. This agreement will offer a unique opportunity for Medifirst Solutions to generate business with its present products and expand into new products and services.

Medifirst Solutions, Inc. (MFST), closed Friday's trading session at $0.073, down 2.01%, on 35,175 volume with 7 trades. The average volume for the last 60 days is 295,566 and the stock's 52-week low/high is $0.0331/$0.26.

Cellceutix Corp. (CTIX)

OTC Showcase, Money Morning, FeedBlitz, AllPennyStocks, and Real Pennies reported previously on Cellceutix Corp. (CTIX), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Cellceutix Corp. is a clinical stage biopharmaceutical company that lists on the OTC Markets’ OTCQB. The Company concentrates on developing and commercializing its pipeline of compounds for novel therapies in areas of serious unmet medical need. This includes cancer, psoriasis, and antibiotic applications.  Cellceutix has formed research collaborations with world-renowned research institutions in the U.S. and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.  The Company’s flagship compound is Kevetrin. This is a novel drug that Cellceutix indicates has shown very promising laboratory data as a new cancer treatment.  Cellceutix is based in Beverly, Massachusetts. 

The Company’s anti-cancer drug Kevetrin is now in a Phase 1 clinical trial for solid tumors at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory, Kevetrin has shown to induce activation of p53. This p53 is often referred to as the "Guardian Angel Gene" because of its vital role in controlling cell mutations.

Cellceutix's key antibiotic is Brilacidin. Brilacidin is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than presently marketed antibiotics for multi-drug resistant bacteria (Superbugs).

The Company is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM is a defensin mimetic compound. It has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by over 94 percent versus placebo.

The Company’s anti-psoriasis drug is Prurisol. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Prurisol is now in a bioequivalence crossover clinical trial.

Last week, Cellceutix reported that patient enrollment was completed in its Phase 1 crossover study of its anti-psoriasis drug candidate Prurisol. The Company expects lab results, pharmacokinetic studies, and analysis to take approximately two months. If the data shows bioequivalence of Prurisol with Abacavir Sulfate, Cellceutix will subsequently schedule a meeting with the U.S. Food and Drug Administration (FDA) concerning initiating a Phase 2/3 trial of Prurisol via the 505(b)(2) regulatory pathway.

Cellceutix Corp. (CTIX), closed Friday's trading session at $1.70, even for the day, on 163,475 volume with 97 trades. The average volume for the last 60 days is 150,634 and the stock's 52-week low/high is $1.40/$2.32.

Daybreak Oil and Gas, Inc. (DBRM)

The Green Baron reported recently on Daybreak Oil and Gas, Inc. (DBRM), Goldman Small Cap Research did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Daybreak Oil and Gas, Inc. is an independent oil and gas company with corporate headquarters in Spokane, Washington. The Company also has an operations office in Friendswood, Texas. Daybreak engages in the exploration, development, and production of oil and natural gas in California and Kentucky. Its basic business model is finding and developing shallow oil and gas reserves by way of exploration and development activities, and selling the production from those reserves at a profit. The Company’s shares trade on the OTC Markets’ OTCQB.

Daybreak Oil and Gas owns a 3-D seismic survey, which covers 20,000 acres over 32 square miles with roughly 6,500 acres under lease in the San Joaquin Valley of California. It operates production from 20 wells in its East Slopes project area in Kern County, California. 

In addition, Daybreak owns a 25 percent working interest (WI) in approximately 7,000 acres under lease in the Appalachian Basin in Lawrence County, Kentucky. Here it is currently participating in a continuing oil development program at the Twin Bottoms field.

Recently, Daybreak Oil and Gas announced the successful drilling of its 9th consecutive successful oil well at the Twin Bottoms Field in Lawrence County, Kentucky. The Gerald Grove H-10 well was drilled to a measured depth (MD) of 4,512 feet. Logs and other measurement data show that the horizontal section of the wellbore encountered 3,000 feet of oil-bearing sandstone.

Yesterday, Daybreak announced that the Gerald Grove H-7 and H-8 wells at the Twin Bottoms Field in Lawrence County, Kentucky were put on production on June 10, 2014. The combined initial flow rate from both wells is around 570 barrels of oil and 150 Mcf of natural gas per day. The Gerald Grove H-7 well is producing approximately 330 barrels of oil and 75 Mcf per day of natural gas. The Gerald Grove H-8 well is producing roughly 240 barrels of oil per day and 75 Mcf per day of natural gas.

Daybreak Oil and Gas, Inc. (DBRM), closed Friday's trading session at $0.30, down 2.91%, on 138,400 volume with 21 trades. The average volume for the last 60 days is 37,976 and the stock's 52-week low/high is $0.11/$0.50.

HC2 Holdings, Inc. (HCHC)

Today we are reporting on HC2 Holdings, Inc. (HCHC), here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, HC2 Holdings, Inc. operates as a holding company of operating subsidiaries chiefly in the U.S. and the UK. HC2's indirectly wholly owned subsidiary is PTGi International Carrier Services, Inc. In addition, HC2 owns approximately 65 percent of Schuff International, Inc. Furthermore, HC2's indirectly wholly owned subsidiary is Genovel Orthopedics, Inc.  The Company was previously known as PTGi Holding, Inc. It changed its name to HC2 Holdings, Inc. this past April. Established in 1994, HC2 Holdings has its corporate headquarters in Herndon, Virginia

PTGi International Carrier Services (PTGi ICS) is one of the top global wholesale service providers to fixed and mobile network operators around the world. PTGi ICS owns and operates its own global network of next-generation IP soft switches and media gateways. 

Schuff International, Inc. is the largest steel fabrication and erection company in the U.S. HC2's Genovel Orthopedics, Inc. is researching the development of innovative products to treat early osteoarthritis of the knee. 

This week, HC2 Holdings announced that Rustin Roach was selected as the new Chief Executive Officer and President of Schuff International, Inc. and Schuff Steel Company, effective June 4, 2014. Former CEO and President, Scott Schuff, will provide advisory services to Schuff over the next three years.

Recently, HC2 Holdings announced that Genovel Orthopedics signed a research and license agreement with New York University for the development and commercialization of a new technology for osteoarthritis of the knee. The technology was designed by Peter S. Walker, PhD; Professor, Department of Orthopaedic Surgery, NYU School of Medicine; Professor, Department of Mechanical & Aerospace Engineering, NYU-Polytechnic, and Joseph Bosco, MD, Associate Professor; Vice Chair for Clinical Affairs, Department of Orthopaedic Surgery, NYU School of Medicine. They designed a next-generation treatment for patients who suffer from osteoarthritis of the knee that strives to improve their quality of life and reduce costs.

HC2 Holdings, Inc. (HCHC), closed Friday's trading session at $4.05, even for the day, on 79,593 volume with 99 trades. The average volume for the last 60 days is 85,528 and the stock's 52-week low/high is $2.25/$4.10.


The QualityStocks
Company Corner


NutraNomics, Inc. (NNRX)

The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.065, off by 3.27%, on 67,548 volume with 14 trades. The stock’s average daily volume over the past 60 days is 194,881, and its 52-week low/high is $0.0605/$1.48.

NutraNomics, Inc. announced today that they are now offering their products on RevNutrition.com. The brand, a top producer of vitamins and supplements, has gained increasing popularity among health enthusiasts for its use of all-natural ingredients. Nutranomics only uses ingredients derived from plants and naturally occurring food sources, as opposed to the synthetically produced supplements offered by many of its competitors.

NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.

Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.

Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.

NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer

NutraNomics, Inc. Company Blog

NutraNomics, Inc. News:

RevNutrition.com to Carry Nutranomics Line of Non-Synthetic Supplements, Vitamins

Nutranomics Discusses Long-Term Global Expansion Strategy with UNO International Corp.

Nutranomics Receives Initial Purchase Order from Leading Health Products Distributor in the Philippines

Armco Metals Holdings, Inc. (AMCO)

The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.343, up 3.94%, on 2,620,833 volume with 1,552 trades. The stock’s average daily volume over the past 60 days is 495,894, and its 52-week low/high is $0.185/$0.58.

Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has worked tirelessly to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.

Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.

Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.

Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer

Armco Metals Holdings, Inc. Company Blog

Armco Metals Holdings, Inc. News:

Armco Metals Holdings, Inc. Receives Government Approval to Import 20,000 Metric Tons of Restricted Materials Annually

Armco Metals Holdings, Inc. Receives $15 Million Credit Approval From a Chinese Commercial Bank

Armco Metals Holdings Announces Financial Results for the First Quarter of 2014

Kallo, Inc. (KALO)

The QualityStocks Daily Newsletter would like to spotlight Kallo, Inc. (KALO). Today, Kallo, Inc. closed trading at $0.079, up 81.19%, on 71,640 volume with 8 trades. The stock’s average daily volume over the past 60 days is 106,509, and its 52-week low/high is $0.0126/$0.45.

Kallo, Inc. (KALO) leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare industry. Offering centralized, congruent solutions that attend healthcare and business issues, the company addresses the needs of hospitals, ministries of health, physicians, and other healthcare organizations.

As a result of an expanding and aging population, coupled with an increasing number of people suffering from chronic diseases and lifestyle related conditions, healthcare expenditures continue to grow. Kallo is focused on introducing new healthcare technology that helps contain costs, enable better methods to monitor/treat medical conditions, and increase the reach of healthcare providers to remote areas.

The tailored solutions offered by Kallo complement existing infrastructure, workflows, and processes, increasing both uptime and productivity. The company’s suite of products complies with international, national, and regional standards, and its stringent quality control ensures repeatable, process-driven delivery for maximum performance.

Kallo’s executives and directors bring rich and diverse industry knowledge. Collectively, the management team reflects the strength of the company’s global network and the diversity of its global culture. The team’s entrepreneurship, passion, experience, and knowledge of healthcare enables Kallo to continually deliver higher standards. Disclaimer

Kallo, Inc. Company Blog

Kallo, Inc. News:

Kallo Inc. - Announces Appointment of Two Senior Managers

Update on US $200,000,925.00 Supply Contract for Kallo MobileCare and RuralCare in Guinea

Kallo Inc. Selects Dell to Provide Technology Infrastructure for Global Healthcare Initiative

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.14, up 3.70%, on 18,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 46,067, and its 52-week low/high is $0.03/$0.41.

Global Payout, Inc. (GOHE) specializes in customized payment solutions for businesses and organizations worldwide. The company’s global network of banks and processing partners enable companies and organizations to efficiently deploy a customized payment solution configured specifically for each client. From solving a single payment issue to meeting an entire global payment requirement, Global Payout in conjunction with its partners delivers modular payment solutions.

Global Payout has a product line of prepaid "off the shelf" products that can be utilized or Global Payout can customize payment solutions for qualified businesses. By coupling its network of international banks and third-party processing relationships with an innovative payment platform, Global Payout enables organizations to "plug into" an efficient and cost effective method of paying employees, contractors, investors, and commissioned agents wherever they might be located in the world.

Global Payout began operations as a business to business provider of pre-paid debit cards for payroll and general spend programs. The company then launched a Prepaid Discover® card to meet the demand of its business clients in the United States. As a result of these efforts and with the input of their client base, Global Payout then greatly extended its reach by developing a new proprietary “payment platform” which enables companies and organizations to make necessary payments in every country a company does business. Clients can now make international payments without the need to establish banking relationships in each and every country they do business. Businesses now have an efficient, compliant and simplified system to make their all necessary international payments using Global Payout’s proprietary payment platform.

Global Payout delivers dependable and secure global payment solutions for companies worldwide. This relieves clients of burdensome and time consuming efforts to establish banking relationships everywhere they do business. The company’s “consolidated payment gateway” product can be configured specifically to the needs of each client within a short period of time. Global Payout is led by a management team comprised of pioneers in domestic and international payment delivery solutions. The company is well positioned to leverage their long standing international financial relationships to expand their services and global reach. Even during this expansion, Global Payout remains committed to serving domestic and international clients and providing them with customized one-stop solutions that address each client’s specific payment needs. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Chip and PIN Prepaid MasterCard® Now Available Internationally

Gateway To 2.5 Billion Under-Banked Adults Rapidly Expanding

Global Payout Wins New Contract To Provide Recurring Payroll Disbursements

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.125, up 2.46%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 7,369 and its 52-week low/high is $0.055/$0.28.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies Appoints Former Microsoft Engineer to Advisory Board

Ecrypt Technologies Forms Advisory Board

Ecrypt Technologies, Inc. Commences Development of a Product Sandbox


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Joe Penny Stocks


Real Pennies


1-2-3 Stock Alerts

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251